You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: May 12, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Bevasiranib

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Bevasiranib?

Bevasiranib is an investigational drug.

There have been 5 clinical trials for Bevasiranib. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2007.

The most common disease conditions in clinical trials are Macular Degeneration, Edema, and Choroidal Neovascularization. The leading clinical trial sponsors are OPKO Health, Inc. and [disabled in preview].

Recent Clinical Trials for Bevasiranib
Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON)OPKO Health, Inc.Phase 3
Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMDOPKO Health, Inc.Phase 3
Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular EdemaOPKO Health, Inc.Phase 2

See all Bevasiranib clinical trials

Clinical Trial Summary for Bevasiranib

Top disease conditions for Bevasiranib
Top clinical trial sponsors for Bevasiranib

See all Bevasiranib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.